RubrYc Therapeutics announces Series A2 Preferred equity financing, collaboration, and RTX-003 license with iBio, Inc.

Must Read

RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of RubrYc’s Series A2 Preferred Financing, and concomitant License and Collaboration Agreements directed towards the …

Latest News

TNI deploys 1,267 personnel for East Nusa Tenggara quake response

Jakarta (ANTARA) - The Indonesian National Armed Forces (TNI) has deployed 1,267 personnel to support disaster response efforts following...

More Articles Like This